Skip to content
DraconiticResearch
Search Sources API
197,693 studies31 sourcesUpdated 4 min ago
Peer-reviewedCC BYCureus

A Rare Suprasellar Ependymoma With Negative Targeted Fusion Testing: Diagnostic Value of Histopathological, Immunohistochemical, and Ultrastructural Findings.

4 affiliations
  1. 1Department of Neurosurgery, Mejiro Daini Hospital, Tokyo, JPN.
  2. 2Department of Neurosurgery, Hongo Neurosurgery Clinic, Saitama, JPN.
  3. 3Department of Neurosurgery, International University of Health and Welfare Mita Hospital, Tokyo, JPN.
  4. 4Department of Neurosurgery, International University of Health and Welfare Narita Hospital, Narita, JPN.

Abstract

Ependymomas arising in the supratentorial region preferentially appear in the third ventricle or cerebral parenchyma, making a suprasellar location extremely rare. We report a case of a 36-year-old woman who presented with incomplete bitemporal hemianopsia and was found to have a suprasellar mass lesion on magnetic resonance imaging. The patient underwent endoscopic transsphenoidal surgery with gross total resection. Pathological analysis of the resected tumor demonstrated perivascular pseudorosettes and immunohistochemical positivity for glial fibrillary acidic protein, vimentin, cytokeratin CAM5.2, and epithelial membrane antigen. Ultrastructural findings revealed intercellular junctional complexes, microvilli, and intermediate filaments on electron microscopy. Molecular analysis using reverse transcription-polymerase chain reaction failed to detect a gene fusion. According to the WHO classification 2021, the tumor was diagnosed as supratentorial ependymoma NEC (not elsewhere classified). To our knowledge, only a small number of cases of ependymoma developing in the suprasellar region have been reported in the literature. Radial glia-like cells present in the adult central nervous system, specifically in the subventricular zone, may serve as the origin for adult supratentorial ependymomas. This case highlights that suprasellar ependymoma, though rare, should be considered in the differential diagnosis of sellar-suprasellar tumors. Molecular testing for defining gene fusions is important for precise classification of future cases.

Related

  1. The Goldfish Limbus as a Specialized Epithelial-Stromal Microenvironment: Histological, Immunohistochemical, and Ultrastructural Characterization.
    Doaa M Mokhtar, Manal T Hussein, Eman Fayad +5
    Veterinary sciencesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Dietary Macronutrient Composition Is Associated with Distinct Hepatic Phenotypes During Post-Weaning Growth: An Integrated Biochemical, Histological, Immunohistochemical and Ultrastructural Study
    Emrah Zayman, Elif Kayhan, Mehmet Erman Erdemli +3
    MetabolitesPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
  3. The Therapeutic Effects of 4-Aminopyridine Administration via Phonophoresis on Sutured Postoperative Wounds: A Histopathological, Immunohistochemical, Molecular, and Morphometric Study
    Selma Yaman, Hamit Yilmaz, Gamze Altun +3
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Mammary secretory carcinoma in a female domestic rabbit (Oryctolagus cuniculus): histopathological and immunohistochemical features.
    Maíra Meira Nunes, Eric Santos Oliveira, Júlia Gabriela Wronski +4
    Veterinary research communicationsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Hepatoprotective and pancreatoprotective effects of Arctium lappa root extract in valproic acid–induced toxicity: biochemical, histopathological, and immunohistochemical analysis
    Mukul Shyam, Sabina Evan Prince
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMCPMC
BibTeX
@article{fujiwara2026rare,
  title = {{A Rare Suprasellar Ependymoma With Negative Targeted Fusion Testing: Diagnostic Value of Histopathological, Immunohistochemical, and Ultrastructural Findings.}},
  author = {Ren Fujiwara and Toshio Hirohata and Kenichi Oyama and Keisuke Onoda and Akira Matsuno},
  journal = {Cureus},
  year = {2026},
  month = oct,
  doi = {10.7759/cureus.117336},
  url = {https://europepmc.org/article/MED/42968710},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - A Rare Suprasellar Ependymoma With Negative Targeted Fusion Testing: Diagnostic Value of Histopathological, Immunohistochemical, and Ultrastructural Findings.
AU  - Ren Fujiwara
AU  - Toshio Hirohata
AU  - Kenichi Oyama
AU  - Keisuke Onoda
AU  - Akira Matsuno
PY  - 2026
DA  - 2026/10/01
JO  - Cureus
DO  - 10.7759/cureus.117336
UR  - https://europepmc.org/article/MED/42968710
AB  - Ependymomas arising in the supratentorial region preferentially appear in the third ventricle or cerebral parenchyma, making a suprasellar location extremely rare. We report a case of a 36-year-old woman who presented with incomplete bitemporal hemianopsia and was found to have a suprasellar mass lesion on magnetic resonance imaging. The patient underwent endoscopic transsphenoidal surgery with gross total resection. Pathological analysis of the resected tumor demonstrated perivascular pseudorosettes and immunohistochemical positivity for glial fibrillary acidic protein, vimentin, cytokeratin CAM5.2, and epithelial membrane antigen. Ultrastructural findings revealed intercellular junctional complexes, microvilli, and intermediate filaments on electron microscopy. Molecular analysis using reverse transcription-polymerase chain reaction failed to detect a gene fusion. According to the WHO classification 2021, the tumor was diagnosed as supratentorial ependymoma NEC (not elsewhere classified). To our knowledge, only a small number of cases of ependymoma developing in the suprasellar region have been reported in the literature. Radial glia-like cells present in the adult central nervous system, specifically in the subventricular zone, may serve as the origin for adult supratentorial ependymomas. This case highlights that suprasellar ependymoma, though rare, should be considered in the differential diagnosis of sellar-suprasellar tumors. Molecular testing for defining gene fusions is important for precise classification of future cases.
SN  - 2168-8184
ER  -